Terms: = Pancreatic cancer AND CUX1, ENSG00000160967, P39880, p75, p200, p110, p100, Nbla10317, CUX, COY1, CDP, CASP, 1523 AND Treatment
17 results:
1. Neurotrophin3 promotes hepatocellular carcinoma apoptosis through the JNK and P38 MAPK pathways.
Yang Z; Zhang H; Yin M; Cheng Z; Jiang P; Feng M; Liao B; Liu Z
Int J Biol Sci; 2022; 18(15):5963-5977. PubMed ID: 36263167
[TBL] [Abstract] [Full Text] [Related]
2. Impact of enteral immunonutrition on infectious complications and immune and inflammatory markers in cancer patients undergoing chemotherapy: A systematic review of randomised controlled trials.
Miller LJ; Douglas C; McCullough FS; Stanworth SJ; Calder PC
Clin Nutr; 2022 Oct; 41(10):2135-2146. PubMed ID: 36067585
[TBL] [Abstract] [Full Text] [Related]
3. Extensive (subtotal) distal pancreatectomy for pancreatic ductal adenocarcinoma: a propensity score matched cohort study of short- and long-term outcomes compared with those of conventional distal pancreatectomy.
Watanabe Y; Nakata K; Mori Y; Ideno N; Ikenaga N; Ohtsuka T; Nakamura M
Langenbecks Arch Surg; 2022 Jun; 407(4):1479-1488. PubMed ID: 35146547
[TBL] [Abstract] [Full Text] [Related]
4. Prevalence and reclassification of BRCA1 and BRCA2 variants in a large, unselected Chinese Han breast cancer cohort.
Liu Y; Wang H; Wang X; Liu J; Li J; Wang X; Zhang Y; Bai Z; Zhou Q; Wu Y; Shen Y; Weng X; Liu F; Guo J; Di L; Gires O; Zhang Z; Chen Y; Wang H
J Hematol Oncol; 2021 Jan; 14(1):18. PubMed ID: 33461583
[TBL] [Abstract] [Full Text] [Related]
5. Fluorouracil, Doxorubicin with Streptozocin and Subsequent Therapies in pancreatic Neuroendocrine Tumors.
Rogers JE; Lam M; Halperin DM; Dagohoy CG; Yao JC; Dasari A
Neuroendocrinology; 2022; 112(1):34-42. PubMed ID: 33434908
[TBL] [Abstract] [Full Text] [Related]
6. Galactosyltransferase B4GALT1 confers chemoresistance in pancreatic ductal adenocarcinomas by upregulating N-linked glycosylation of CDK11
Chen Y; Su L; Huang C; Wu S; Qiu X; Zhao X; Meng Q; Meng YM; Kong X; Wang M; Liu C; Wong PP
Cancer Lett; 2021 Mar; 500():228-243. PubMed ID: 33309857
[TBL] [Abstract] [Full Text] [Related]
7. Targeted PARP Inhibition Combined with FGFR1 Blockade is Synthetically Lethal to Malignant Cells in Patients with pancreatic cancer.
Lai SW; Bamodu OA; Chen JH; Wu AT; Lee WH; Chao TY; Yeh CT
Cells; 2020 Apr; 9(4):. PubMed ID: 32276472
[TBL] [Abstract] [Full Text] [Related]
8. Early liver metastases in resectable periampullary cancer: Incidence and risk factors.
Guerard AS; Ayav A; Busby H; Lafitte M; Rousseau H; Laurent V
Eur J Radiol; 2017 Aug; 93():265-272. PubMed ID: 28668425
[TBL] [Abstract] [Full Text] [Related]
9. Impact of FDG-PET findings on decisions regarding patient management strategies: a multicenter trial in patients with lung cancer and other types of cancer.
Kubota K; Matsuno S; Morioka N; Adachi S; Koizumi M; Seto H; Kojo M; Nishioka S; Nishimura M; Yamamoto H
Ann Nucl Med; 2015 Jun; 29(5):431-41. PubMed ID: 25812534
[TBL] [Abstract] [Full Text] [Related]
10. cux1: a modulator of tumour aggressiveness in pancreatic neuroendocrine neoplasms.
Krug S; Kühnemuth B; Griesmann H; Neesse A; Mühlberg L; Boch M; Kortenhaus J; Fendrich V; Wiese D; Sipos B; Friemel J; Gress TM; Michl P
Endocr Relat Cancer; 2014; 21(6):879-90. PubMed ID: 25248790
[TBL] [Abstract] [Full Text] [Related]
11. Borderline resectable pancreatic cancer: definitions and management.
Lopez NE; Prendergast C; Lowy AM
World J Gastroenterol; 2014 Aug; 20(31):10740-51. PubMed ID: 25152577
[TBL] [Abstract] [Full Text] [Related]
12. Upregulation of extrinsic apoptotic pathway in curcumin-mediated antiproliferative effect on human pancreatic carcinogenesis.
Youns M; Fathy GM
J Cell Biochem; 2013 Dec; 114(12):2654-65. PubMed ID: 23794119
[TBL] [Abstract] [Full Text] [Related]
13. Desensitization of NFκB for overcoming chemoresistance of pancreatic cancer cells to TNF-α or paclitaxel.
Fujioka S; Son K; Onda S; Schmidt C; Scrabas GM; Okamoto T; Fujita T; Chiao PJ; Yanaga K
Anticancer Res; 2012 Nov; 32(11):4813-21. PubMed ID: 23155247
[TBL] [Abstract] [Full Text] [Related]
14. [Surgical treatment of pancreatic adenocarcinoma using cephalic duodenopancreatectomy (Part 2). Long term follow up after 204 cases].
Fabregat J; Busquets J; Peláez N; Jorba R; García-Borobia F; Masuet C; Valls C; Ruiz-Osuna S; Serrano T; Galán M; Cambray M; Laquente B; Ramos E; Rafecas A
Cir Esp; 2010 Dec; 88(6):374-82. PubMed ID: 21030012
[TBL] [Abstract] [Full Text] [Related]
15. [Surgical treatment of pancreatic adenocarcinoma by cephalic duodenopancreatectomy (Part 1). Post-surgical complications in 204 cases in a reference hospital].
Busquets J; Fabregat J; Jorba R; Peláez N; García-Borobia F; Masuet C; Valls C; Martínez-Carnicero L; Lladó L; Torras J
Cir Esp; 2010 Nov; 88(5):299-307. PubMed ID: 20663494
[TBL] [Abstract] [Full Text] [Related]
16. NIK is involved in constitutive activation of the alternative NF-kappaB pathway and proliferation of pancreatic cancer cells.
Nishina T; Yamaguchi N; Gohda J; Semba K; Inoue J
Biochem Biophys Res Commun; 2009 Oct; 388(1):96-101. PubMed ID: 19646419
[TBL] [Abstract] [Full Text] [Related]
17. Fixed dose-rate gemcitabine infusion as first-line treatment for advanced-stage carcinoma of the pancreas and biliary tree.
Gelibter A; Malaguti P; Di Cosimo S; Bria E; Ruggeri EM; Carlini P; Carboni F; Ettorre GM; Pellicciotta M; Giannarelli D; Terzoli E; Cognetti F; Milella M
Cancer; 2005 Sep; 104(6):1237-45. PubMed ID: 16078261
[TBL] [Abstract] [Full Text] [Related]
